Cue Biopharma Inc
NASDAQ:CUE

Watchlist Manager
Cue Biopharma Inc Logo
Cue Biopharma Inc
NASDAQ:CUE
Watchlist
Price: 0.2687 USD 11.49%
Market Cap: 21.2m USD

Intrinsic Value

The intrinsic value of one CUE stock under the Base Case scenario is 2.6762 USD. Compared to the current market price of 0.2687 USD, Cue Biopharma Inc is Undervalued by 90%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CUE Intrinsic Value
2.6762 USD
Undervaluation 90%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Cue Biopharma Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CUE?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CUE valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cue Biopharma Inc.

Explain Valuation
Compare CUE to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CUE?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cue Biopharma Inc

Current Assets 25.8m
Cash & Short-Term Investments 18.7m
Receivables 2.3m
Other Current Assets 4.9m
Non-Current Assets 5.8m
PP&E 4.9m
Other Non-Current Assets 916k
Current Liabilities 15.5m
Accounts Payable 2.3m
Accrued Liabilities 3.6m
Other Current Liabilities 9.6m
Non-Current Liabilities 2.9m
Long-Term Debt 190k
Other Non-Current Liabilities 2.7m
Efficiency

Free Cash Flow Analysis
Cue Biopharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cue Biopharma Inc

Revenue
7.1m USD
Operating Expenses
-45.2m USD
Operating Income
-38.1m USD
Other Expenses
424k USD
Net Income
-37.7m USD
Fundamental Scores

CUE Profitability Score
Profitability Due Diligence

Cue Biopharma Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Declining Net Margin
Low Gross Margin
Declining Operating Margin
11/100
Profitability
Score

Cue Biopharma Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

CUE Solvency Score
Solvency Due Diligence

Cue Biopharma Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
46/100
Solvency
Score

Cue Biopharma Inc's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CUE Price Targets Summary
Cue Biopharma Inc

There are no price targets for CUE.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Cue Biopharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CUE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CUE Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CUE stock?

The intrinsic value of one CUE stock under the Base Case scenario is 2.6762 USD.

Is CUE stock undervalued or overvalued?

Compared to the current market price of 0.2687 USD, Cue Biopharma Inc is Undervalued by 90%.

Back to Top